2025-05-15T06:43:38-05:00 2024-06-30 390859910 BAKER TILLY ADVISORY GROUP LP 20 STANWIX STREET PITTSBURGH PA 15222 990 2023-07-01 251781357 NSABP FOUNDATION INC NSAB 4123395300 2 ALLEGHENY CENTER 1200 PITTSBURGH PA 15212 CARL NESBITT CFO 4123395300 2025-05-14 1 1 JEFFREY J SPENGLER CPA P00109764 4126976400 2025-05-13 2023 2025-03-06 01:10:19Z PRIAYA RASTOGI 2 ALLEGHENY CENTER 1200 PITTSBURGH PA 15212 47902348 0 X WWW.NSABP.ORG X 1995 PA DESIGN AND CONDUCT CLINICAL STUDIES IN BREAST AND COLORECTAL CANCER TO IMPROVE TREATMENT AND ADVANCE THE STANDARD OF CARE. 7 5 107 6 0 0 3932873 4280581 36769123 30488650 2559067 1709998 959969 1123278 44221032 37602507 25000 15000 0 0 8089244 7267366 0 0 0 28414674 26799826 36528918 34082192 7692114 3520315 97902542 112171594 41573654 41975533 56328888 70196061 DESIGN AND CONDUCT CLINICAL STUDIES IN BREAST AND COLORECTAL CANCER TO IMPROVE TREATMENT AND ADVANCE THE STANDARD OF CARE. 0 0 34081985 15000 30488650 THE USE OF CLINICAL TRIALS TO FURTHER THE UNDERSTANDING OF BREAST AND COLORECTAL CANCERS AND TO USE THIS INFORMATION TO REDUCE THE INCIDENCE OF THESE CANCERS. 34081985 1 1 0 0 0 0 0 0 0 0 1 0 0 1 1 1 1 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 26 0 107 1 0 0 0 0 0 0 0 0 0 0 0 0 X 7 5 1 0 0 0 0 0 0 1 1 0 0 0 1 1 1 1 1 1 1 0 PA X JULIE KARDELL SR DIRECTOR OF FINA 4123395319 2 ALLEGHENY CENTER SUITE 1200 PITTSBURGH PA 15212 X EVA BLUM DIRECTOR 1.00 X 0 0 0 HARRY BEAR MD PHD DIRECTOR 1.00 X 0 0 0 NORMAN WOLMARK MD CHAIR 10.00 4.00 X X 200003 0 0 PAT HALPIN-MURPHY MS DIRECTOR 1.00 X 0 0 0 PRIYA RASTOGI MD CHIEF EXECUTIVE OFFICER 39.00 1.00 X X 60000 0 0 SALLY MCCRADY DIRECTOR 1.00 X 0 0 0 SANDY SWAIN MD DIRECTOR 1.00 X 0 0 0 CHARLES GEYER MD CHIEF SCIENTIFIC OFFICER 40.00 X 0 0 0 RONALD SUGAR ESQ CHIEF FINANCIAL OFFICER 40.00 X 300564 0 35290 SHEILA EVANS DNP CHIEF OPERATING OFFICER 40.00 X 279085 0 13041 FRANCES FONZI DIRECTOR PROTOCOL DEVELOPMENT 40.00 X 134766 0 15133 HOPE ALCORN PROTOCOL NURSE 40.00 X 107478 0 11283 JUDY LANGER DIRECTOR OF REGULATORY AFFAIRS 40.00 X 100894 0 11532 JULIE KARDELL SR. DIRECTOR OF FINANCE 40.00 X 167457 0 29188 KRISTEN KOTSKO DIRECTOR OF CLINICAL COORDINATING 40.00 X 110762 0 27039 LISA QUIGLEY DIRECTOR OF HUMAN RESOURCES 40.00 X 102182 0 12971 MARK BLOOM DIRECTOR OF CONTRACTS 40.00 X 159524 0 15272 MARTHA DUNCAN PROTOCOL NURSE SPECIALIST 40.00 X 106233 0 13356 PATRICIA SCHAEFER PROTOCOL NURSE 40.00 X 110819 0 28540 RANDY POLJAK DIRECTOR OF ACCOUNTING 40.00 X 129598 0 12793 REBECCA JOHNSON ASSOCIATE DIRECTOR OF SITE AND STUDY MANAGEMENT 39.00 X 115845 0 13404 STEVE NICHOLSON DIRECTOR OF FINANCIAL PLANNING AND ANALYSIS 40.00 X 127628 0 26879 SUDHEER KOMMAREDDY DIRECTOR OF DATA MANAGEMENT 40.00 X 119534 0 32737 THOMAS JULIAN ASSOC. DIR. OF MEDICAL AFFAIRS 39.00 1.00 X 114999 0 0 2547371 0 298458 17 0 1 0 ERMILI POTKA 24018 ENCLAVE DRIVE SOUTH LYON MI 48178 MONITORING 309795 KIMBERLY HAAS 4717 NEEDLE ROAD DECATUR IL 62626 MONITORING 303060 UNIVERSITY OF PITTSBURGH 3420 FORBES AVENUE PITTSBURGH PA 15260 CONSULTING 278675 LINDA ROBITAILLE 1109 SECOND AVENUE VERDUN CA H4G2W9 MONITORING 235280 RENEE RAKVICA 525 AUSTIN OAKS DRIVE GRAPEVINE TX 76051 MONITORING 197195 6 4206617 73964 4280581 RESEARCH PROGRAM FUNDING 541700 29646375 29646375 OTHER INDUSTRY RESEARCH PROGRAMS 541700 842275 842275 30488650 2367127 2367127 9642712 10299519 322 -656807 -322 -657129 -657129 SERVICE REIMBURSEMENT FROM NRG ON 900099 761553 761553 SERVICE REIMBURSEMENT FROM RTOG F 900099 321874 321874 OTHER REVENUE 900099 39851 39851 1123278 37602507 30488650 0 2833276 15000 15000 817171 604706 212465 5043115 3653285 1389830 953423 1120341 -166918 453657 453657 73845 73845 146000 146000 2810355 2124837 685518 642040 195113 446927 1519625 297 1519328 782133 616013 166120 131153 131153 71862 387 71475 SUBCONTRACTS 11835136 11835136 SITE PAYMENTS 8162958 8162958 PURCHASED SERVICES 363533 88236 275297 PROGRAM COSTS 185479 185479 0 75707 5480197 -5404490 34082192 34081985 207 0 22495556 15830654 6276913 13467553 287565 185350 12319773 11529933 220450 789840 59830650 71786651 2778988 2771097 6012420 7340449 97902542 112171594 7969251 6801419 28457879 28755236 5146524 6418878 41573654 41975533 X 56159088 70046261 169800 149800 56328888 70196061 97902542 112171594 X 3520315 10461933 -115075 X 0 1 X 1 1 1 X 3336762 4227527 3678961 3932873 4280581 19456704 3336762 4227527 3678961 3932873 4280581 19456704 19456704 1485091 946335 2110469 2790241 2367127 9699263 554588 873887 912734 959969 1123278 4424456 33580423 167215093 0.57940 0.59410 X SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME: SERVICE REIMBURSMENT FROM NRG ONCOLOGY FOUNDATION INC - 2019 AMOUNT: $ 554,588. 2020 AMOUNT: $ 873,887. 2021 AMOUNT: $ 912,734. 2022 AMOUNT: $ 667,980. 2023 AMOUNT: $ 761,553. SERVICE REIMBURSMENT FROM RTOG FOUNDATION INC - 2022 AMOUNT: $ 215,830. 2023 AMOUNT: $ 321,874. OTHER REVENUE - 2022 AMOUNT: $ 76,159. 2023 AMOUNT: $ 39,851. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 89800 89800 89800 89800 29750 60050 89800 29750 29750 0.00000 1.00000 0.00000 0 0 1581898 1070461 511437 10737875 10459472 278403 789840 457 ASSETS 569767 OPERATING LEASE RIGHT-OF-USE ASSETS 5939093 RECEIVABLE FROM NRG ONCOLOGY FOUNDATION, INC. 831589 7340449 OPERATING LEASE LIABILITY 6418878 6418878 X 47803365 10461933 -261075 10200858 37602507 0 37602507 33936192 0 33936192 146000 146000 34082192 PART V, LINE 4: THE PURPOSE OF THE FUND IS TO PROVIDE FINANCIAL SUPPORT FOR EITHER OPERATING EXPENSES OR CAPITAL EXPENSES OF NSABP. PART X, LINE 2: THE FOUNDATION QUALIFIES AS A TAX-EXEMPT ORGANIZATION UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE. ACCORDINGLY, NO PROVISION FOR FEDERAL AND STATE INCOME TAX IS RECORDED IN THE ACCOMPANYING FINANCIAL STATEMENTS. THE FOUNDATION ACCOUNTS FOR UNCERTAINTY IN INCOME TAXES USING A RECOGNITION THRESHOLD OF MORE LIKELY THAN NOT TO BE SUSTAINED UPON EXAMINATION BY THE APPROPRIATE TAXING AUTHORITY. MEASUREMENT OF THE TAX UNCERTAINTY OCCURS IF THE RECOGNITION THRESHOLD IS MET. MANAGEMENT DETERMINED THAT THERE WERE NO TAX UNCERTAINTIES THAT MET THE RECOGNITION THRESHOLD IN 2024 AND 2023. THE FOUNDATION'S POLICY IS TO RECOGNIZE INTEREST AND PENALTY COSTS RELATING TO UNRECOGNIZED TAX BENEFITS OR OBLIGATIONS, IF ANY, IN GENERAL AND ADMINISTRATIVE EXPENSES. PART XI, LINE 2D - OTHER ADJUSTMENTS: CHANGE IN VALUE OF INTEREST IN NET ASSETS OF NRG ONCOLOGY FOUNDATION, INC. -115,075. INVESTMENT MGT. FEES NETTED AGAINST REVENUE ON FINANCIALS -146,000. PART XII, LINE 4B - OTHER ADJUSTMENTS: INVESTMENT MGT. FEES NETTED AGAINST REVENUE ON FINANCIALS 146,000. 0 PENNSYLVANIA BREAST CANCER COALITION 2397 QUENTIN RD STE B LEBANON PA 170429236 251722323 501(C)(3) 15000 0 GENERAL SUPPORT GENERAL SUPPORT 1 0 X X 0 0 0 0 0 0 0 0 0 RONALD SUGAR ESQ CHIEF FINANCIAL OFFICER 300564 0 0 0 0 0 12023 0 23267 0 335854 0 0 0 SHEILA EVANS DNP CHIEF OPERATING OFFICER 279085 0 0 0 0 0 11163 0 1878 0 292126 0 0 0 NORMAN WOLMARK MD CHAIR 200003 0 0 0 0 0 0 0 0 0 200003 0 0 0 JULIE KARDELL SR. DIRECTOR OF FINANCE 167457 0 0 0 0 0 6698 0 22490 0 196645 0 0 0 MARK BLOOM DIRECTOR OF CONTRACTS 159524 0 0 0 0 0 6381 0 8891 0 174796 0 0 0 STEVE NICHOLSON DIRECTOR OF FINANCIAL PLANNING AND A 127628 0 0 0 0 0 5105 0 21774 0 154507 0 0 0 SUDHEER KOMMAREDDY DIRECTOR OF DATA MANAGEMENT 119534 0 0 0 0 0 4781 0 27956 0 152271 0 0 0 FORM 990, PART VI, SECTION A, LINE 2 LISA QUIGLEY AND JULIE KARDELL HAVE A FAMILY RELATION. FORM 990, PART VI, SECTION B, LINE 11B MANAGEMENT DETAIL REVIEWED DRAFT COPY OF 990 WITH THE FINAL COPY PROVIDED TO THE BOARD OF DIRECTORS. FORM 990, PART VI, SECTION B, LINE 12C ON AN ANNUAL BASIS, CONFLICT OF INTEREST DISCLOSURES ARE SENT TO ALL APPLICABLE BOARD MEMBERS, SENIOR MANAGEMENT, AND KEY EMPLOYEES IN WHICH SAID PERSONS PROACTIVELY DISCLOSE ANY POTENTIAL CONFLICTS OF INTEREST. FORM 990, PART VI, SECTION B, LINE 15 THE COMPENSATION OF SENIOR MANAGEMENT IS REVIEWED BY AN INDEPENDENT OUTSIDE CONSULTANT AND RECOMMENDATIONS FORMULATED BY A COMPENSATION SUBCOMMITTEE ARE PRESENTED TO THE CHAIRMAN FOR APPROVAL. A REPORT OF THE PROCESS AND CHAIRMAN'S DECISION IS MADE TO THE FULL BOARD OF DIRECTORS. COMPENSATION OF EMPLOYEES IS REVIEWED BY SENIOR MANAGEMENT ANNUALLY. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION'S GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS ARE MADE AVAILABLE UPON REQUEST. FORM 990, PART VII, SECTION A: THE FOUNDATION PAYS TO THE UNIVERSITY OF PITTSBURGH FOR THE CONSULTANCY SERVICES RENDERED BY THE FOLLOWING INDIVIDUALS LISTED ON PART VII, SECTION A: - CHARLES GEYER, MD (CHIEF SCIENTIFIC OFFICER) WITH CALENDAR YEAR COMPENSATION OF $278,675 FORM 990, PART XI, LINE 9: CHANGE IN VALUE OF INTEREST IN NET ASSETS OF NRG ONCOLOGY FOUNDATION, INC. -115,075. NRG ONCOLOGY FOUNDATION INC 1600 JFK BOULEVARD SUITE 1020 PHILADELPHIA PA 19103 900912747 ONCOLOGY RESEARCH SUPPORT PA 501(C)(3) LINE 7 N/A 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0